Contact
Allon Home Page
  ProfileLeadershipIn the News TechnologyMarketIndicationsPublications Development StatusAL-108AL208Pre-clinicalPartnering News ReleasesInformation RequestShareholder ReportsConference/WebStock QuoteAnalyst RequestInformation Request
 

June 23, 2008
Allon Therapeutics Enters into Agreement for a $20 Million Bought Deal of Common Shares

June 17, 2008
Allon Therapeutics human efficacy data to be featured at world's leading Alzheimer's disease conference

May 23, 2008
Allon completes dosing in Phase II cognitive impairment trial

arrow

Interview
Gordon McCauley
CEO

 

Copyright 2005 Allon Therapeutics Inc.  See legal terms for use of this site.